Literature DB >> 29894638

The Structure of an As(III) S-Adenosylmethionine Methyltransferase with 3-Coordinately Bound As(III) Depicts the First Step in Catalysis.

Charles Packianathan1, Palani Kandavelu2, Barry P Rosen1.   

Abstract

Arsenic is a ubiquitous environmental toxic substance and a Class 1 human carcinogen. Arsenic methylation by the enzyme As(III) S-adenosylmethionine (SAM) methyltransferase (ArsM in microbes or AS3MT in animals) detoxifies As(III) in microbes but transforms it into more toxic and potentially more carcinogenic methylated species in humans. We previously proposed a reaction pathway for ArsM/AS3MT that involves initial 3-coordinate binding of As(III). To date, reported structures have had only 2-coordinately bound trivalent arsenicals. Here we report a crystal structure of CmArsM from Cyanidioschyzon sp.5508 in which As(III) is 3-coordinately bound to three conserved cysteine residues with a molecule of the product S-adenosyl-l-homocysteine bound in the SAM binding site. We propose that this structure represents the first step in the catalytic cycle. In a previously reported SAM-bound structure, a disulfide bond is formed between two conserved cysteine residues. Comparison of these two structures indicates that there is a conformational change in the N-terminal domain of CmArsM that moves a loop to allow formation of the 3-coordinate As(III) binding site. We propose that this conformational change is an initial step in the As(III) SAM methyltransferase catalytic cycle.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29894638      PMCID: PMC6172949          DOI: 10.1021/acs.biochem.8b00457

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the ArsM arsenic(III) S-adenosylmethionine methyltransferase.

Authors:  Kavitha Marapakala; A Abdul Ajees; Jie Qin; Banumathi Sankaran; Barry P Rosen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-26

Review 2.  Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.

Authors:  David J Thomas; Jiaxin Li; Stephen B Waters; Weibing Xing; Blakely M Adair; Zuzana Drobna; Vicenta Devesa; Miroslav Styblo
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  Human adaptation to arsenic-rich environments.

Authors:  Carina M Schlebusch; Lucie M Gattepaille; Karin Engström; Marie Vahter; Mattias Jakobsson; Karin Broberg
Journal:  Mol Biol Evol       Date:  2015-03-03       Impact factor: 16.240

5.  High-throughput identification of catalytic redox-active cysteine residues.

Authors:  Dmitri E Fomenko; Weibing Xing; Blakely M Adair; David J Thomas; Vadim N Gladyshev
Journal:  Science       Date:  2007-01-19       Impact factor: 47.728

6.  A disulfide-bond cascade mechanism for arsenic(III) S-adenosylmethionine methyltransferase.

Authors:  Kavitha Marapakala; Charles Packianathan; A Abdul Ajees; Dharmendra S Dheeman; Banumathi Sankaran; Palani Kandavelu; Barry P Rosen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-02-26

7.  Biotransformation of arsenic by a Yellowstone thermoacidophilic eukaryotic alga.

Authors:  Jie Qin; Corinne R Lehr; Chungang Yuan; X Chris Le; Timothy R McDermott; Barry P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

Review 8.  Carcinogenic and systemic health effects associated with arsenic exposure--a critical review.

Authors:  Paul B Tchounwou; Anita K Patlolla; Jose A Centeno
Journal:  Toxicol Pathol       Date:  2003 Nov-Dec       Impact factor: 1.902

9.  The genomics of disulfide bonding and protein stabilization in thermophiles.

Authors:  Morgan Beeby; Brian D O'Connor; Carsten Ryttersgaard; Daniel R Boutz; L Jeanne Perry; Todd O Yeates
Journal:  PLoS Biol       Date:  2005-08-23       Impact factor: 8.029

Review 10.  Biomarkers of exposure: a case study with inorganic arsenic.

Authors:  Michael F Hughes
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

View more
  7 in total

Review 1.  Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms.

Authors:  Jiaojiao Li; Chunxiao Sun; Wenwen Cai; Jing Li; Barry P Rosen; Jian Chen
Journal:  Mutat Res Rev Mutat Res       Date:  2021-10-07       Impact factor: 7.015

Review 2.  Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Authors:  Miroslav Stýblo; Abhishek Venkatratnam; Rebecca C Fry; David J Thomas
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 5.153

3.  Functional characterization of the methylarsenite-inducible arsRM operon from Noviherbaspirillum denitrificans HC18.

Authors:  Jun Zhang; Jian Chen; Yi-Fei Wu; Xia Liu; Charles Packianathan; Venkadesh S Nadar; Barry P Rosen; Fang-Jie Zhao
Journal:  Environ Microbiol       Date:  2022-01-26       Impact factor: 5.491

Review 4.  Arsenic toxicokinetic modeling and risk analysis: Progress, needs and applications.

Authors:  Elaina M Kenyon
Journal:  Toxicology       Date:  2021-05-07       Impact factor: 4.571

5.  Arsenic 3 methyltransferase (AS3MT) automethylates on cysteine residues in vitro.

Authors:  Sofiane Y Mersaoui; Cynthia Guilbert; Hsiang Chou; Christelle Douillet; D Scott Bohle; Miroslav Stýblo; Stéphane Richard; Koren K Mann
Journal:  Arch Toxicol       Date:  2022-03-04       Impact factor: 6.168

6.  The Human Gut Microbiome's Influence on Arsenic Toxicity.

Authors:  Michael Coryell; Barbara A Roggenbeck; Seth T Walk
Journal:  Curr Pharmacol Rep       Date:  2019-11-25

Review 7.  Recent Advances in Arsenic Research: Significance of Differential Susceptibility and Sustainable Strategies for Mitigation.

Authors:  Tamalika Sanyal; Pritha Bhattacharjee; Somnath Paul; Pritha Bhattacharjee
Journal:  Front Public Health       Date:  2020-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.